Parakh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.24 M
- Revenue Growth %
- Profit Growth 3.78%
- Ebitda
- Net Worth -0.15%
- Total Assets
About Parakh Pharmaceuticals
Parakh Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 July 1997 and has a history of 27 years and six months. Its registered office is in Kanpur Dehat, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.24 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Shukla and Surendra Tiwari serve as directors at the Company.
Company Details
-
Location
Kanpur Dehat, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231UP1997PTC022308
-
Company No.
022308
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jul 1997
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Parakh Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Shukla
|
Director | 07-Aug-2008 | Current |
|
Surendra Tiwari
|
Director | 16-Oct-1997 | Current |
Financial Performance of Parakh Pharmaceuticals.
Parakh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.78% increase in profit. The company's net worth dipped by a decrease of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parakh Pharmaceuticals?
In 2021, Parakh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Surabhi Extractions Private LimitedSurendra Tiwari is a mutual person
-
Pooja Edible Products Private Limited
Surendra Tiwari is a mutual person
-
Saint Remedies Private Limited
Surendra Tiwari is a mutual person
-
Pooja Merchandisers Private Limited
Surendra Tiwari is a mutual person
Charges (Loans)
₹0
₹2.24 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2007 | Bank Of India | ₹2.24 M | Satisfied |
How Many Employees Work at Parakh Pharmaceuticals?
Unlock and access historical data on people associated with Parakh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parakh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parakh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
